BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 1900875)

  • 1. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
    Nelson BJ; Ralph P; Green SJ; Nacy CA
    J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
    J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
    Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A
    Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
    Davis CE; Belosevic M; Meltzer MS; Nacy CA
    J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
    Belosevic M; Davis CE; Meltzer MS; Nacy CA
    J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.
    Green SJ; Meltzer MS; Hibbs JB; Nacy CA
    J Immunol; 1990 Jan; 144(1):278-83. PubMed ID: 2104889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.
    Oswald IP; Gazzinelli RT; Sher A; James SL
    J Immunol; 1992 Jun; 148(11):3578-82. PubMed ID: 1588047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by transforming growth factor-beta 1 of expression and function of the receptor for IFN-gamma on mouse macrophages.
    Pinson DM; LeClaire RD; Lorsbach RB; Parmely MJ; Russell SW
    J Immunol; 1992 Sep; 149(6):2028-34. PubMed ID: 1387670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T; Meltzer MS; Fortier AH
    J Immunol; 1994 Aug; 153(3):1238-45. PubMed ID: 8027551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages.
    Jun CD; Choi BM; Kim SU; Lee SY; Kim HM; Chung HT
    Immunology; 1995 May; 85(1):114-9. PubMed ID: 7635512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
    Wyler DJ; Beller DI; Sypek JP
    J Immunol; 1987 Feb; 138(4):1246-9. PubMed ID: 3100630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; AntĂșnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
    Oster CN; Nacy CA
    J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
    Nacy CA; Meltzer MS; Fortier AH
    J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor.
    Green SJ; Chen TY; Crawford RM; Nacy CA; Morrison DC; Meltzer MS
    J Immunol; 1992 Sep; 149(6):2069-75. PubMed ID: 1381395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.